MLB: Red Sox RHP Lucas Giolito to undergo elbow procedure

Date:

Share post:


Boston Red Sox right-hander Lucas Giolito will undergo elbow surgery Tuesday to determine the severity of an injury that occurred earlier in spring training, multiple outlets reported.

Giolito, 29, was signed by the Red Sox this past offseason to a two-year, $38.5 million deal, with the first year of that contract in danger of being a wash. While Tommy John surgery was a possibility, that will not be determined until Tuesday’s procedure in Birmingham, Ala.

The initial injury was diagnosed as a partial tear in Giolito’s ulnar collateral ligament as well as a forearm flexor tendon strain.

An All-Star in 2019 for the Chicago White Sox, when he also finished sixth in American League Cy Young Award voting, Giolito has struggled in recent seasons, delivering a 4.90 ERA in 2022 and a 4.88 mark last season when he went 8-15 while pitching for the White Sox, Los Angeles Angels and Cleveland Guardians.

In eight major league seasons, Giolito is 61-62 in 180 appearances (178 starts) and has a 4.43 ERA with 1,077 strikeouts in 1,013 2/3 innings.

Giolito had Tommy John surgery in 2012, while still getting drafted in the first round by the Washington Nationals, even though he needed the procedure.

–Field Level Media

spot_img

Related articles

MLB: Dodgers RHP Brusdar Graterol out until midseason after shoulder surgery

Los Angeles Dodgers reliever Brusdar Graterol underwent surgery on his right shoulder and will be out until the...

MLB: Blue Jays tab David Bell as VP of baseball operations

The Toronto Blue Jays hired former Cincinnati Reds manager David Bell as vice president of baseball operations and...

MLB: Al ‘The Bull’ Ferrara dies at 84

Former outfielder Al "The Bull" Ferrara died Friday, the Los Angeles Dodgers announced. He was 84. Ferrara was part...

MLB: Prospect Jett Williams injures ankle, Mets optimistic

New York Mets prospect Jett Williams injured his ankle running into the outfield wall in the Arizona Fall...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.